X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-24 | DGX | Quest Diagnostics Inc | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale | $143.08 | -420 | 5,019 | -8% | -$60,094 | ||||||
| DM | 2024-07-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $105.88 | -1,558 | 77,418 | -2% | -$164,956 | |||||
2024-07-22 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $105.16 | -549 | 113,637 | 0% | -$57,733 | ||||||
2024-07-22 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $105.16 | -549 | 109,391 | 0% | -$57,732 | ||||||
| D | 2024-07-22 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $105.16 | -2,638 | 210,377 | -1% | -$277,410 | |||||
| D | 2024-07-22 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $105.16 | -815 | 207,457 | 0% | -$85,704 | |||||
2024-07-16 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $25.00 | -7,500 | 33,228 | -18% | -$187,500 | ||||||
2024-07-16 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $25.00 | -1,277 | 82,968 | -2% | -$31,925 | ||||||
2024-07-16 | VCYT | Veracyte, Inc. | Holstein Jens | Dir | S - Sale | $24.50 | -5,000 | 32,878 | -13% | -$122,500 | ||||||
2024-07-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $111.66 | -5,496 | 207,855 | -3% | -$613,672 | ||||||
2024-07-01 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $21.22 | -2,793 | 148,618 | -2% | -$59,279 | ||||||
2024-07-01 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $108.87 | -2,700 | 438,972 | -1% | -$293,945 | ||||||
| D | 2024-07-01 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $108.37 | -2,723 | 206,772 | -1% | -$295,080 | |||||
| D | 2024-07-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $108.10 | -37,500 | 213,351 | -15% | -$4,053,805 | |||||
| D | 2024-07-01 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $108.37 | -4,983 | 75,059 | -6% | -$539,987 | |||||
| D | 2024-06-21 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $15.68 | -350 | 8,460 | -4% | -$5,488 | |||||
2024-06-18 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $109.66 | -2,700 | 441,672 | -1% | -$296,080 | ||||||
| M | 2024-06-17 | RDNT | Radnet, Inc. | Patel Mital | EVP, Chief Admin Officer | S - Sale | $59.26 | -40,000 | 202,146 | -17% | -$2,370,200 | |||||
2024-06-17 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $1.29 | -5,055 | 127,751 | -4% | -$6,521 | ||||||
2024-06-17 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $1.29 | -7,176 | 176,012 | -4% | -$9,257 | ||||||
2024-06-17 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $1.29 | -1,585 | 69,081 | -2% | -$2,045 | ||||||
2024-06-17 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $111.61 | -6,105 | 213,351 | -3% | -$681,372 | ||||||
| M | 2024-06-17 | RDNT | Radnet, Inc. | Spurlock Gregory E. | Dir | S - Sale | $59.75 | -14,334 | 2,591 | -85% | -$856,457 | |||||
2024-06-12 | RDNT | Radnet, Inc. | Murdock Michael N | EVP, Mergers, Acquisitions | S - Sale | $62.51 | -10,000 | 63,144 | -14% | -$625,100 | ||||||
2024-06-14 | RDNT | Radnet, Inc. | Levitt Lawrence L | Dir | S - Sale | $57.77 | -4,000 | 172,657 | -2% | -$231,080 | ||||||
2024-06-12 | RDNT | Radnet, Inc. | Forthuber Stephen M | Pres, COO-Eastern Operations | S - Sale | $62.33 | -40,000 | 523,561 | -7% | -$2,493,200 | ||||||
| M | 2024-06-11 | RDNT | Radnet, Inc. | Sorensen Alma Gregory | EVP, Chief Science Officer | S - Sale | $61.97 | -15,000 | 1,255,633 | -1% | -$929,600 | |||||
2024-06-11 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $20.59 | -3,870 | 29,255 | -12% | -$79,683 | ||||||
2024-06-12 | FTRE | Fortrea Holdings Inc. | Hanson James S. | GC | P - Purchase | $25.30 | +2,000 | 7,500 | +36% | +$50,600 | ||||||
| M | 2024-06-10 | RDNT | Radnet, Inc. | Swartz David L | Dir | S - Sale | $60.75 | -25,000 | 233,495 | -10% | -$1,518,841 | |||||
2024-06-10 | RDNT | Radnet, Inc. | Stolper Mark | EVP, CFO | S - Sale | $61.27 | -25,000 | 80,398 | -24% | -$1,531,750 | ||||||
2024-06-10 | RDNT | Radnet, Inc. | Levitt Lawrence L | Dir | S - Sale | $60.85 | -16,000 | 174,066 | -8% | -$973,600 | ||||||
| M | 2024-06-10 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale | $61.75 | -73,597 | 252,211 | -23% | -$4,544,799 | |||||
2024-06-07 | RDNT | Radnet, Inc. | Katz David Jeffrey | EVP, GC | S - Sale | $61.26 | -16,400 | 65,441 | -20% | -$1,004,664 | ||||||
| M | 2024-06-07 | RDNT | Radnet, Inc. | Gordon Christine Nayoma | Dir | S - Sale | $61.21 | -4,500 | 10,879 | -29% | -$275,445 | |||||
2024-06-10 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $8.11 | -26,867 | 869,245 | -3% | -$217,891 | ||||||
2024-06-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $8.11 | -5,415 | 310,481 | -2% | -$43,916 | ||||||
2024-06-10 | VCYT | Veracyte, Inc. | Bhanji Muna | Dir | S - Sale | $20.32 | -3,870 | 23,105 | -14% | -$78,634 | ||||||
| D | 2024-06-07 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $20.97 | -2,500 | 33,125 | -7% | -$52,425 | |||||
2024-06-03 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $23.40 | -6,336 | 394,856 | -2% | -$148,273 | ||||||
| D | 2024-06-04 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale+OE | $27.87 | -100 | 4,621 | -2% | -$2,787 | |||||
2024-05-30 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $110.17 | -2,000 | 18,634 | -10% | -$220,330 | ||||||
2024-05-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $109.96 | -1,647 | 114,186 | -1% | -$181,103 | ||||||
2024-05-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $109.96 | -1,438 | 109,940 | -1% | -$158,122 | ||||||
2024-05-28 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $109.09 | -4,856 | 5,005 | -49% | -$529,728 | ||||||
2024-05-28 | VCYT | Veracyte, Inc. | Bhanji Muna | Dir | S - Sale | $21.00 | -1,539 | 26,975 | -5% | -$32,319 | ||||||
2024-05-29 | FTRE | Fortrea Holdings Inc. | Pike Thomas | CEO | P - Purchase | $24.81 | +10,000 | 57,827 | +21% | +$248,066 | ||||||
2024-05-23 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $108.30 | -1,000 | 444,372 | 0% | -$108,301 | ||||||
2024-05-17 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $1.38 | -940 | 132,806 | -1% | -$1,297 | ||||||
2024-05-17 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $1.38 | -1,333 | 183,188 | -1% | -$1,840 | ||||||
2024-05-17 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $1.38 | -1,731 | 70,666 | -2% | -$2,389 | ||||||
2024-05-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $107.08 | -6,779 | 219,456 | -3% | -$725,911 | ||||||
2024-05-16 | XGN | Exagen Inc. | Aballi John | Pres, CEO | P - Purchase | $1.92 | +40,401 | 641,189 | +7% | +$77,570 | ||||||
2024-05-14 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $24.27 | -6,336 | 401,192 | -2% | -$153,753 | ||||||
2024-05-14 | LH | Laboratory Corp of America Holdings | Van Der Vaart Sandra D | EVP, GC | S - Sale | $210.83 | -2,000 | 5,637 | -26% | -$421,655 | ||||||
2024-05-15 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $8.24 | -10,387 | 185,300 | -5% | -$85,589 | ||||||
| D | 2024-05-10 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $104.59 | -30,000 | 204,495 | -13% | -$3,137,567 | |||||
2024-05-10 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $105.11 | -2,700 | 457,225 | -1% | -$283,794 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $9.59 | -4,205 | 154,833 | -3% | -$40,326 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.59 | -4,902 | 134,869 | -4% | -$47,010 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $9.59 | -4,902 | 145,277 | -3% | -$47,010 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $9.59 | -6,592 | 315,896 | -2% | -$63,217 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $9.59 | -11,992 | 896,112 | -1% | -$115,003 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $9.59 | -4,902 | 140,795 | -3% | -$47,010 | ||||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $1.48 | -244 | 9,915 | -2% | -$361 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $1.48 | -434 | 124,248 | 0% | -$642 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $1.48 | -468 | 75,524 | -1% | -$692 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $1.48 | -3,764 | 483,780 | -1% | -$5,569 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $1.48 | -980 | 171,680 | -1% | -$1,450 | |||||
2024-05-06 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $24.64 | -23,323 | 59,740 | -28% | -$574,679 | ||||||
2024-05-06 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $24.72 | -6,336 | 407,528 | -2% | -$156,626 | ||||||
2024-05-01 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $93.97 | -1,866 | 67,542 | -3% | -$175,344 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Coward D Scott | Dir | S - Sale | $60.15 | -67 | 49,337 | 0% | -$4,030 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Cunningham Everett | Chief Commercial Officer | S - Sale | $60.15 | -136 | 47,613 | 0% | -$8,180 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Herriott James | SVP, GC, Sec | S - Sale | $60.15 | -30 | 11,049 | 0% | -$1,805 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale | $60.15 | -136 | 13,380 | -1% | -$8,180 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM., Precision Oncology | S - Sale | $60.15 | -110 | 13,733 | -1% | -$6,617 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $60.15 | -102 | 78,337 | 0% | -$6,135 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Orville Jacob A | GM, Screening | S - Sale | $60.15 | -102 | 15,557 | -1% | -$6,135 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale | $60.15 | -1,155 | 1,394,770 | 0% | -$69,473 | ||||||
2024-04-30 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $1.37 | -4,523 | 72,397 | -6% | -$6,197 | ||||||
| M | 2024-04-30 | LH | Laboratory Corp of America Holdings | Anderson Kerrii B | Dir | S - Sale | $202.12 | -500 | 16,010 | -3% | -$101,058 | |||||
2024-04-29 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $93.14 | -929 | 110,748 | -1% | -$86,526 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $93.14 | -1,196 | 115,833 | -1% | -$111,394 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $93.14 | -1,057 | 204,495 | -1% | -$98,448 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.14 | -4,084 | 226,235 | -2% | -$380,378 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $93.14 | -1,238 | 69,408 | -2% | -$115,306 | ||||||
2024-04-29 | LH | Laboratory Corp of America Holdings | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale | $204.33 | -2,439 | 2,087 | -54% | -$498,358 | ||||||
2024-04-29 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $140.00 | -1,760 | 15,344 | -10% | -$246,400 | ||||||
2024-04-25 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $89.55 | -1,000 | 459,528 | 0% | -$89,550 | ||||||
| M | 2024-04-24 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $91.67 | -2,393 | 70,646 | -3% | -$219,365 | |||||
| D | 2024-04-24 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $17.06 | -350 | 7,731 | -4% | -$5,971 | |||||
2024-04-23 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.11 | -1,126 | 413,864 | 0% | -$22,643 | ||||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $91.38 | -787 | 205,552 | 0% | -$71,915 | |||||
2024-04-23 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $91.38 | -531 | 117,029 | 0% | -$48,522 | ||||||
2024-04-23 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $91.38 | -522 | 111,677 | 0% | -$47,700 | ||||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $91.38 | -2,552 | 230,319 | -1% | -$233,200 | |||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $91.38 | -1,523 | 73,039 | -2% | -$139,171 | |||||
2024-04-16 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.82 | -80,000 | 117,560 | -40% | -$7,265,651 | ||||||
2024-04-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.13 | -6,816 | 227,710 | -3% | -$634,797 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |